• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎的诊断与治疗。

Diagnosis and management of rheumatoid arthritis.

机构信息

Boston University School of Medicine, MA, 02118-2526, USA.

出版信息

Am Fam Physician. 2011 Dec 1;84(11):1245-52.

PMID:22150658
Abstract

Rheumatoid arthritis is the most commonly diagnosed systemic inflammatory arthritis. Women, smokers, and those with a family history of the disease are most often affected. Criteria for diagnosis include having at least one joint with definite swelling that is not explained by another disease. The likelihood of a rheumatoid arthritis diagnosis increases with the number of small joints involved. In a patient with inflammatory arthritis, the presence of a rheumatoid factor or anti-citrullinated protein antibody, or elevated C-reactive protein level or erythrocyte sedimentation rate suggests a diagnosis of rheumatoid arthritis. Initial laboratory evaluation should also include complete blood count with differential and assessment of renal and hepatic function. Patients taking biologic agents should be tested for hepatitis B, hepatitis C, and tuberculosis. Earlier diagnosis of rheumatoid arthritis allows for earlier treatment with disease-modifying antirheumatic agents. Combinations of medications are often used to control the disease. Methotrexate is typically the first-line drug for rheumatoid arthritis. Biologic agents, such as tumor necrosis factor inhibitors, are generally considered second-line agents or can be added for dual therapy. The goals of treatment include minimization of joint pain and swelling, prevention of radiographic damage and visible deformity, and continuation of work and personal activities. Joint replacement is indicated for patients with severe joint damage whose symptoms are poorly controlled by medical management.

摘要

类风湿关节炎是最常见的系统性炎症性关节炎。女性、吸烟者和有家族病史的人最常受到影响。诊断标准包括至少有一个关节明显肿胀,不能用其他疾病来解释。类风湿关节炎的诊断可能性随着受累小关节数量的增加而增加。在患有炎症性关节炎的患者中,类风湿因子或抗瓜氨酸蛋白抗体的存在,或 C 反应蛋白水平或红细胞沉降率升高提示类风湿关节炎的诊断。初始实验室评估还应包括全血细胞计数和差异评估以及肾功能和肝功能评估。正在服用生物制剂的患者应进行乙型肝炎、丙型肝炎和结核病检测。类风湿关节炎的早期诊断可更早地使用疾病修饰抗风湿药物进行治疗。通常使用药物组合来控制疾病。甲氨蝶呤通常是类风湿关节炎的一线药物。生物制剂,如肿瘤坏死因子抑制剂,通常被认为是二线药物,或可用于双重治疗。治疗的目标包括最大限度地减轻关节疼痛和肿胀,预防影像学损伤和可见畸形,以及继续工作和个人活动。对于症状经药物治疗控制不佳且关节严重受损的患者,需要进行关节置换。

相似文献

1
Diagnosis and management of rheumatoid arthritis.类风湿关节炎的诊断与治疗。
Am Fam Physician. 2011 Dec 1;84(11):1245-52.
2
Rheumatoid Arthritis: Common Questions About Diagnosis and Management.类风湿关节炎:诊断和管理常见问题。
Am Fam Physician. 2018 Apr 1;97(7):455-462.
3
Diagnosis and management of rheumatoid arthritis.类风湿关节炎的诊断与管理
Am Fam Physician. 2005 Sep 15;72(6):1037-47.
4
Emerging trends in diagnosis and treatment of rheumatoid arthritis.类风湿关节炎诊断与治疗的新趋势
Prim Care. 2010 Dec;37(4):779-92, vii. doi: 10.1016/j.pop.2010.07.001.
5
Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.甲氨蝶呤治疗类风湿关节炎失败后二线改善病情抗风湿药的选择:基于风湿病学家偏好的临床实践决策树
Arthritis Rheum. 2009 Apr 15;61(4):425-34. doi: 10.1002/art.24588.
6
Occurrence of rheumatoid arthritis requiring oral and/or biological disease-modifying antirheumatic drug therapy following a diagnosis of primary Sjögren syndrome.原发性干燥综合征诊断后需要口服和/或生物改善病情抗风湿药治疗的类风湿关节炎的发生情况。
J Clin Rheumatol. 2012 Oct;18(7):356-8. doi: 10.1097/RHU.0b013e31826d2abb.
7
Rheumatoid arthritis: symptoms, diagnosis, and management.类风湿性关节炎:症状、诊断与管理
Nurs Times. 2004;100(24):40-4.
8
Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.类风湿关节炎:抗风湿治疗的选择。首选甲氨蝶呤。
Prescrire Int. 2010 Feb;19(105):30-4.
9
Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.在早期预后不良的类风湿性关节炎中,除甲氨蝶呤外,早期使用英夫利昔单抗治疗可减少滑膜炎和损伤的磁共振成像证据,在停用英夫利昔单抗后仍有持续益处:一项为期十二个月的随机、双盲、安慰剂对照试验的结果。
Arthritis Rheum. 2005 Jan;52(1):27-35. doi: 10.1002/art.20712.
10
Early rheumatoid arthritis.早期类风湿关节炎
Curr Opin Rheumatol. 2007 May;19(3):278-83. doi: 10.1097/BOR.0b013e32805e87bf.

引用本文的文献

1
The causal relationship between immune cells and rheumatoid arthritis: A dual sample Mendelian randomization study.免疫细胞与类风湿性关节炎之间的因果关系:一项双样本孟德尔随机化研究。
Medicine (Baltimore). 2025 Jul 4;104(27):e43145. doi: 10.1097/MD.0000000000043145.
2
Differential Gene Expression in Rheumatoid Arthritis: Implication in the Diagnosis and Individualized Treatment Plan.类风湿关节炎中的差异基因表达:对诊断和个体化治疗方案的意义
J Biotechnol Biomed. 2025;8(2):148-158. doi: 10.26502/jbb.2642-91280187. Epub 2025 May 28.
3
Global, regional, and national burdens of rheumatoid arthritis among people aged 60 years and older from 1990 to 2021: a trend analysis for the Global Burden of Disease Study 2021.
1990年至2021年60岁及以上人群中类风湿关节炎的全球、区域和国家负担:全球疾病负担研究2021的趋势分析
Front Public Health. 2025 May 26;13:1527680. doi: 10.3389/fpubh.2025.1527680. eCollection 2025.
4
Gene Variant rs255758 Provides Susceptibility to Rheumatoid Arthritis in Northwest Indian Population.基因变体rs255758使印度西北部人群易患类风湿性关节炎。
Int J Appl Basic Med Res. 2025 Jan-Mar;15(1):38-42. doi: 10.4103/ijabmr.ijabmr_156_24. Epub 2025 Jan 9.
5
The association between social determinants of health and all-cause, cardiovascular mortality in US rheumatoid arthritis: a cohort study of NHANES.美国类风湿关节炎患者健康的社会决定因素与全因死亡率、心血管死亡率之间的关联:一项基于美国国家健康与营养检查调查(NHANES)的队列研究
BMC Public Health. 2025 Apr 22;25(1):1491. doi: 10.1186/s12889-025-22706-3.
6
Stimuli-Responsive Nanomedicines for the Treatment of Non-cancer Related Inflammatory Diseases.用于治疗非癌症相关炎症性疾病的刺激响应性纳米药物。
ACS Nano. 2025 Apr 29;19(16):15189-15219. doi: 10.1021/acsnano.5c00700. Epub 2025 Apr 18.
7
Immune cells differentiation in osteoarthritic cartilage damage: friends or foes?骨关节炎软骨损伤中免疫细胞的分化:朋友还是敌人?
Front Immunol. 2025 Mar 25;16:1545284. doi: 10.3389/fimmu.2025.1545284. eCollection 2025.
8
AI-Assisted Plasmonic Diagnostics Platform for Osteoarthritis and Rheumatoid Arthritis With Biomarker Quantification Using Mathematical Models.用于骨关节炎和类风湿性关节炎的人工智能辅助等离子体诊断平台,通过数学模型进行生物标志物定量分析。
Small. 2025 May;21(18):e2500264. doi: 10.1002/smll.202500264. Epub 2025 Mar 30.
9
Sensor-assessed grasping time as a biomarker of functional impairment in rheumatoid arthritis.传感器评估的抓握时间作为类风湿性关节炎功能损害的生物标志物
Sci Rep. 2025 Feb 19;15(1):6018. doi: 10.1038/s41598-025-90295-7.
10
Essential role of the metabolite α-ketoglutarate in bone tissue and bone-related diseases.代谢物α-酮戊二酸在骨组织及骨相关疾病中的重要作用
Acta Biochim Biophys Sin (Shanghai). 2025 Feb 19;57(8):1207-1221. doi: 10.3724/abbs.2025020.